- Home
- IMRN vs MTEX Comparison
IMRN vs MTEX Comparison
Compare IMRN & MTEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMRN
- MTEX
- Stock Information
- Founded
- IMRN 1994
- MTEX 1993
- Country
- IMRN Australia
- MTEX United States
- Employees
- IMRN N/A
- MTEX N/A
- Industry
- IMRN Biotechnology: Pharmaceutical Preparations
- MTEX Medicinal Chemicals and Botanical Products
- Sector
- IMRN Health Care
- MTEX Health Care
- Exchange
- IMRN Nasdaq
- MTEX Nasdaq
- Market Cap
- IMRN 15.0M
- MTEX 23.0M
- IPO Year
- IMRN N/A
- MTEX 1999
- Fundamental
- Price
- IMRN $1.96
- MTEX $11.87
- Analyst Decision
- IMRN Strong Buy
- MTEX
- Analyst Count
- IMRN 1
- MTEX 0
- Target Price
- IMRN $5.00
- MTEX N/A
- AVG Volume (30 Days)
- IMRN 6.1K
- MTEX 6.5K
- Earning Date
- IMRN 12-31-2024
- MTEX 11-12-2024
- Dividend Yield
- IMRN N/A
- MTEX N/A
- EPS Growth
- IMRN N/A
- MTEX N/A
- EPS
- IMRN N/A
- MTEX N/A
- Revenue
- IMRN $3,271,194.00
- MTEX $121,552,000.00
- Revenue This Year
- IMRN N/A
- MTEX N/A
- Revenue Next Year
- IMRN N/A
- MTEX N/A
- P/E Ratio
- IMRN N/A
- MTEX N/A
- Revenue Growth
- IMRN 171.67
- MTEX N/A
- 52 Week Low
- IMRN $1.59
- MTEX $6.75
- 52 Week High
- IMRN $5.96
- MTEX $13.00
- Technical
- Relative Strength Index (RSI)
- IMRN 45.89
- MTEX 61.96
- Support Level
- IMRN $2.05
- MTEX $11.13
- Resistance Level
- IMRN $2.23
- MTEX $12.40
- Average True Range (ATR)
- IMRN 0.17
- MTEX 0.84
- MACD
- IMRN -0.00
- MTEX 0.06
- Stochastic Oscillator
- IMRN 29.69
- MTEX 74.89
About IMRN Immuron Limited
Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.
About MTEX Mannatech Incorporated
Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.